Having a range of Covid-19 vaccines available for people to use around the world will be essential to bringing the pandemic under control. Here’s why.
Preliminary data from phase III clinical trials has shown the Pfizer-BioNTech and Moderna Covid-19 vaccines to be more than 90% effective. So, how do they work, are they safe, and when will they be available?
We've introduced a new vision and strategy for Wellcome that we hope will have significant positive impacts on the course of human health over the next two decades.
Effective treatments, that are accessible to everyone who needs them, have to be part of the solution to the coronavirus pandemic – here's why.
The world is waiting eagerly for Covid-19 vaccines to be developed as quickly as possible. But to make sure they are safe and effective, the clinical trials that test them have to be robust. So how do trials achieve this?
As we'll soon start to see the results of the first vaccines coming through late-stage clinical trials, Jeremy Farrar explains why we should be cautiously optimistic.
As global efforts continue to make sure COVID-19 tests, treatments and vaccines are available to those who need them the most, Will Hall writes about the importance of a coordinated global response, delivered locally.
Six months on from the first case of COVID-19, the pandemic is accelerating and spreading into new areas. Jeremy Farrar talks about the lessons we learned and the long-term solutions.
Researchers may well identify a safe, effective vaccine for COVID-19 before too long, but all that fantastic work could count for nothing unless we also invest in the next stages of the vaccine process – manufacturing and delivery.
With measures to prevent the spread of COVID-19 disrupting immunisation around the globe, millions are now at risk of other deadly diseases. We must act and invest urgently to maintain routine immunisation.
On 4 May, world leaders and health organisations pledged billions for the COVID-19 response. Alex Harris explains that urgent funding gaps remain for research.